Donald Maxwell Parkin, M.D. graduated in
medicine in 1968 and specialised in public
health/epidemiology in 1973. From 1981-2004
he was head of Descriptive
Epidemiology at the International Agency for
Research on Cancer (WHO) in Lyon, France. He
was responsible for monitoring global
patterns and trends of cancer, was principal
editor for 3 volumes of the “Cancer
Incidence in Five Continents” series, and
initiated the much-used GLOBOCAN estimates
of world cancer burden. Currently, he is
President of the International Association
of Cancer Registries (IACR), a society
dedicated to furthering the work of cancer
registration worldwide, and a consultant to
the cancer registry in Kampala, Uganda,
where several studies on the role of HIV
infection on cancer risk have been carried
Since 2005, he has been Senior Research
Fellow, Clinical Trials Service Unit and
Epidemiological Studies Unit, Oxford
University, working on quantitative
estimation of cancer and the impact of
different risk factors (Infections, tobacco,
obesity) on patterns and trends of cancer
internationally, and acting as consultant to
WHO, the EU, the Institute of Medicine,
American Cancer Society and the National
Cancer Institute of Thailand.
In May 2006 he joined the Cancer Research UK
Centre for Epidemiology, Mathematics and
Statistics, Wolfson Institute of Preventive
Medicine, as a Senior Epidemiologist, where
he is responsible for preparing, on behalf
of Cancer Research UK a set of “scenarios”
for cancer in the UK. This comprises
projections of cancer incidence and
mortality to the year 2025, with plausible
estimates of the potential impact of
different interventions in prevention, early
diagnosis/screening and treatment. The
ultimate objective is to allow rational
prioritisation of the work of CRUK. He holds
honorary professorships at the Karolinska
Institute (Stockholm) and at the Medical
Universities of Peking and Tianjin, China.
He has published more than 300 papers in the
Parkin, D.M., Whelan, S.L., Ferlay, J.,
Teppo, L. and Thomas, D.B.eds (2002)
Cancer Incidence in Five Continents,
VIII. IARC Scientific Publications No.
Parkin, D.M., Ferlay, J., Hamdi-Chérif,
M., Sitas, F., Thomas, J.O., Wabinga, H.
and Whelan, S.L. (eds) (2003) Cancer in
Africa: Epidemiology and Prevention.
IARC Scientific Publications No.153,
IARC, Lyon, France
Parkin DM, Bray F, Ferlay J, Pisani P
Global cancer statistics, 2002.CA
Cancer J Clin. 2005;55:74-108.
Sankaranarayanan R, Nene BM, Dinshaw KA,
Mahe C, Jayant K, Shastri SS, Malvi SG,
Chinoy R, Kelkar R, Budukh AM, Keskar V,
Rajeshwarker R, Muwonge R, Kane S,
Parkin DM. A cluster randomized
controlled trial of visual, cytology and
human papillomavirus screening for
cancer of the cervix in rural India. Int
J Cancer. 2005 ;116: 617-23. Parkin DM,
Bray F. Descriptive Studies. In Ahrens W
& OPigeot I (eds) Handbook of
epidemiology, 1st Edn. 2005.
P, Parkin DM, Ngelangel C, Esteban D,
Gibson L, Munson M, Reyes MG, Laudico A.
Outcome of screening by clinical
examination of the breast in a trial in
Int J Cancer. 2006; 118: 149-54.
Mbulaiteye SM, Katabira ET, Wabinga H,
Parkin DM, Virgo P, Ochai R, Workneh M,
Coutinho A, Engels EA.
Spectrum of cancers among HIV-infected
persons in Africa: the Uganda
AIDS-Cancer Registry Match Study.
Int J Cancer. 2006 Feb 15;118(4):985-90.
Parkin DM. The global health burden of
infection-associated cancers in the year
2002.Int J Cancer.
2006 Jun 15;118(12):3030-44.
Parkin DM. The evolution of the
population-based cancer registry.
Nat Rev Cancer. 2006 Aug;6(8):603-12.
Parkin DM, Bray F. Chapter 2: The
burden of HPV-related cancers.Vaccine.
2006 Aug 21;24 Suppl 3:S11-25.
Mackay J, Jemal A, Lee NC, Parkin DM (eds)
The Cancer Atlas. Atlanta, Ga. American
Cancer Society, 2006
Parkin DM & Bray F. International
Patterns of Cancer Incidence and
Mortality , in Cancer Epidemiology and
Prevention, Third Edition. Edited by
David Schottenfeld and Joseph F.
Fraumeni. August 2006. Oxford University